Cellular response to alkylating agent MNNG is impaired in STAT1-deficients cells

Laurent Ah-Koon1,2, Denis Lesage1,2, Elodie Lemadre1,2

  • 1INSERM, U978, Bobigny, France.

Insights

Signal transducer and activator of transcription 1 (STAT1) is crucial for cellular response to DNA damage from alkylating agents like MNNG. STAT1 promotes DNA repair and cell survival, suggesting it as a therapeutic target.

Area of Science:

  • Molecular Biology
  • Cellular Biology
  • Cancer Research

Background:

  • SN1 alkylating agents trigger the mismatch repair system, causing cell cycle arrest and DNA repair.
  • Signal transducer and activator of transcription 1 (STAT1) is an anti-proliferative and pro-apoptotic factor influencing DNA damage response.
  • STAT1 is known to enhance p53 activity and modulate cellular responses to DNA damage.

Purpose of the Study:

  • To investigate the role of STAT1 in modulating cell fate after mismatch repair system activation by the alkylating agent N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
  • To determine if STAT1 influences DNA repair, cell cycle progression, and survival following MNNG exposure.

Main Methods:

  • Utilized STAT1-proficient and STAT1-deficient cell lines for comparative analysis.
  • Assessed DNA lesion levels, phosphorylation of CHK2 and p53, G2/M checkpoint progression, and long-term cell survival after MNNG treatment.
  • Investigated the composition of p53-DNA complexes, including STAT1, c-Abl, and MLH1, and the role of c-Abl tyrosine kinase activity.

Main Results:

  • STAT1 is essential for reducing DNA lesions, rapid phosphorylation of T68-CHK2 and S15-p53, and G2/M checkpoint progression after MNNG exposure.
  • STAT1 is required for long-term survival following MNNG treatment.
  • STAT1 facilitates the formation of a p53-DNA complex with c-Abl and MLH1, linking c-Abl activity to MNNG-induced toxicity.

Conclusions:

  • STAT1 plays a critical modulatory role in the signaling pathway activated by the mismatch repair system in response to MNNG.
  • STAT1's ability to promote resistance to MNNG highlights the potential of targeting the STAT1 pathway to enhance chemotherapy efficacy.
  • Targeting STAT1 may represent a therapeutic strategy to improve outcomes for patients treated with SN1 alkylating agents.

Related Concept Videos

DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
10.3K
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
3.3K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.3K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
13.7K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
9.1K